On Aug 10, 2021 LQT Therapeutics closed a Series A round and raised $19,000,000 from Alexandria Venture Investments, Amplitude Venture Capital, Amzak Health Investors, Fonds de solidarité FTQ, Lumira Ventures, featuring lead investors Amplitude Venture Capital.

About the company: LQT Therapeutics is located at Canada, North America.
“LQT Therapeutics is a biopharmaceutical company discovering and developing
SGK1 inhibition therapies for Long QT Syndrome and various cardiovascular
diseases and cancers.”

Company website: lqttrx.com/